This site is intended for health professionals only

High hopes for lupus drug trial

teaser

Scientists are anticipating a breakthrough in the treatment of patients with a chronic inflammatory disease ahead of a final phase III trial of the drug belimumab.

BLISS-76 is the second of two pivotal phase III randomised clinical trials of LymphoStat-B (belimumab) in patients with active systemic lupus erythematosus (lupus).

The drug is being developed by Human Genome Sciences (HGS) and GlaxoSmithKline under a joint development and commercialisation project agreed in August 2006.

“If LymphoStat-B is successful in phase III, we believe that it could represent a breakthrough in the treatment of patients suffering from lupus,” said H Thomas Watkins, president and chief executive of HGS.

“We are on track to have data from our first phase III trial by mid-2009, and data from our second phase III trial by autumn 2009. Assuming positive results, we anticipate a BLA (Biologic Licence Application) filing in the United States in the first half of 2010.”

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

BLISS-76 began in February last year and has enrolled 826 patients in 19 countries, mainly in North America and Europe. The first phase III trial, BLISS-52, completed the enrolment of 867 patients in Asia, South America and Eastern Europe this April.

Copyright PA Business 2008

Human Genome Sciences

Your comments: (terms and conditions apply)

“Yes, I do have high hopes. My wife has suffered from SLE since 2000. Although the flares are less common, we are still suffering from side affects from all 7 medications she is currently taking.” – JC, Atlanta, USA






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x